J&J's single-shot Covid-19 vaccine: the journey to approval
Data Science and Digital Health at Janssen R&D - YouTube
Johnson & Johnson Unveils New Vaccines Launch Facility in Holland
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses | npj Vaccines
UK, Baptist Health Lexington and Norton Healthcare Begin Recruiting Participants for Phase 3 COVID-19 Investigational Vaccine Clinical Trial | UKNow
Latest COVID-19 vaccine based on technology tested for safety & immunogenicity in IMI Ebola projects | IMI Innovative Medicines Initiative
COVID-19 Vaccine Janssen, INN-Ad26.COV2-S, recombinant
Frontiers | A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
J&J partners HHS to speed-up coronavirus vaccine development
Janssen Vaccine Technologies | Janssen EMEA
AdventHealth begins recruiting participants for Phase 3 COVID-19 Investigational vaccine clinical trial | AdventHealth Research Institute
Janssen Investigational COVID-19 Vaccine Program
Janssen discontinues Phase 3 HIV vaccine trial
Janssen Investigational COVID-19 Vaccine Program
J&J's Janssen Speeds Up Planned Launch of COVID-19 Vaccine Trial
J&J statement on Janssen vaccine approval | Healthcare Purchasing News
Janssen to supply 100 million Covid-19 vaccine doses to US - Pharmaceutical Technology
Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
